Denali Therapeutics investor relations material

Listen to the latest call from Denali Therapeutics

Denali Therapeutics, Inc. is a biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company has been operating its business since 2013.

  • Ticker

    DNLI
  • Country

    US

Dig deeper into the Denali Therapeutics fundamentals on Quartr.